Literature DB >> 32679473

Self-regulation and emotional reactivity in infants with prenatal exposure to opioids and alcohol.

Kathryn G Beauchamp1, Jean Lowe2, Ronald M Schrader3, Shikhar Shrestha4, Crystal Aragón2, Natalia Moss5, Julia M Stephen6, Ludmila N Bakhireva7.   

Abstract

BACKGROUND: Infants with prenatal substance exposure are at increased risk for developmental problems, with self-regulatory challenges being some of the most pronounced. The current study aimed to investigate the extent to which prenatal substance exposure (alcohol, opioids) impacts infant self-regulation during a relational stressor and the association between self-regulation and infant affect.
METHODS: Participants were 100 mother-child dyads recruited prenatally (Mean = 23.8 gestational weeks) and completed the Still Face Paradigm (SFP) when infants were 5 to 8 months of age (Mean = 6.9 months) as part of an ENRICH prospective birth cohort study. Based on prospective repeated assessment of maternal substance use in pregnancy, infants were grouped into: 1) Unexposed controls; 2) Alcohol-exposed; 3) Opioid-exposed due to maternal use of medications for opioid use disorder (MOUD) with or without other opioids; 4) MOUD and alcohol. Infant stress reactivity (negative affect) and self-regulation were assessed during the validated 5-episode SFP. Mixed effects linear models were used to analyze differences in the percent of self-regulation and percent of negative affect among the study groups across SFP episodes, as well as the group-by-self-regulation interaction with respect to infant negative affect.
RESULTS: The MOUD+Alcohol group demonstrated significantly lower self-regulation at baseline compared to controls (p < 0.05). There was a significant group-by-self-regulation interaction (p = 0.028). Higher self-regulation was associated with lower negative affect across SFP episodes in the MOUD+Alcohol group (p = 0.025) but not other groups.
CONCLUSION: Self-regulation skills are particularly important for emotional modulation in infants with prenatal polysubstance exposure, highlighting the development of these skills as a promising intervention target.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Year:  2020        PMID: 32679473      PMCID: PMC7478127          DOI: 10.1016/j.earlhumdev.2020.105119

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  54 in total

Review 1.  Fetal Alcohol Spectrum Disorders: A Review of the Neurobehavioral Deficits Associated With Prenatal Alcohol Exposure.

Authors:  Sarah N Mattson; Gemma A Bernes; Lauren R Doyle
Journal:  Alcohol Clin Exp Res       Date:  2019-05-02       Impact factor: 3.455

Review 2.  Third pathophysiology of prenatal cocaine exposure.

Authors:  Barry M Lester; James F Padbury
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

Review 3.  Behavioral effects of perinatal opioid exposure.

Authors:  Anna Fodor; Júlia Tímár; Dóra Zelena
Journal:  Life Sci       Date:  2014-04-15       Impact factor: 5.037

Review 4.  Defining the behavioral phenotype in children with fetal alcohol spectrum disorders: a review.

Authors:  P W Kodituwakku
Journal:  Neurosci Biobehav Rev       Date:  2006-08-23       Impact factor: 8.989

5.  Maternal prenatal stress and infant regulatory capacity in Mexican Americans.

Authors:  Betty Lin; Keith A Crnic; Linda J Luecken; Nancy A Gonzales
Journal:  Infant Behav Dev       Date:  2014-08-09

6.  The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.

Authors:  Barry M Lester; Edward Z Tronick; Linda LaGasse; Ronald Seifer; Charles R Bauer; Seetha Shankaran; Henrietta S Bada; Linda L Wright; Vincent L Smeriglio; Jing Lu; Loretta P Finnegan; Penelope L Maza
Journal:  Pediatrics       Date:  2002-12       Impact factor: 7.124

Review 7.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

8.  ANXIETY AND DEPRESSION DURING PREGNANCY AND TEMPERAMENT IN EARLY INFANCY: FINDINGS FROM A MULTI-ETHNIC, ASIAN, PROSPECTIVE BIRTH COHORT STUDY.

Authors:  Shang-Chee Chong; Birit Fp Broekman; Anqi Qiu; Izzuddin M Aris; Yiong Huak Chan; Anne Rifkin-Graboi; Evelyn Law; Cornelia Yin Ing Chee; Yap-Seng Chong; Kenneth Y C Kwek; Seang Mei Saw; Peter D Gluckman; Michael J Meaney; Helen Chen
Journal:  Infant Ment Health J       Date:  2016-08-22

Review 9.  The effects of parental opioid use on the parent-child relationship and children's developmental and behavioral outcomes: a systematic review of published reports.

Authors:  Magdalena Romanowicz; Jennifer L Vande Voort; Julia Shekunov; Tyler S Oesterle; Nuria J Thusius; Teresa A Rummans; Paul E Croarkin; Victor M Karpyak; Brian A Lynch; Kathryn M Schak
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2019-01-12       Impact factor: 3.033

10.  Consumption of Alcohol Beverages and Binge Drinking Among Pregnant Women Aged 18-44 Years - United States, 2015-2017.

Authors:  Clark H Denny; Cristian S Acero; Timothy S Naimi; Shin Y Kim
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-04-26       Impact factor: 17.586

View more
  3 in total

Review 1.  Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants.

Authors:  Lori A Devlin; Leslie W Young; Walter K Kraft; Elisha M Wachman; Adam Czynski; Stephanie L Merhar; T Winhusen; Hendrée E Jones; Brenda B Poindexter; Lauren S Wakschlag; Amy L Salisbury; Abigail G Matthews; Jonathan M Davis
Journal:  J Perinatol       Date:  2021-09-23       Impact factor: 3.225

2.  Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome.

Authors:  Ludmila N Bakhireva; Rajesh C Miranda; Amanda H Mahnke; Melissa H Roberts; Lawrence Leeman; Xingya Ma
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

3.  Fifty Years of Research on Prenatal Substances: Lessons Learned for the Opioid Epidemic.

Authors:  Lynn T Singer; Christina Chambers; Claire Coles; Julie Kable
Journal:  Advers Resil Sci       Date:  2020-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.